1. State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China; 2. Clinical Metabolomics Center, China Pharmaceutical University, Nanjing 211198, China. * The authors contributed equally to the work.
✉ Corresponding author: Dr. Lian-Wen Qi, Clinical Metabolomics Center, China Pharmaceutical University, No. 639 Longmian Road, Nanjing 211198, China, Email: Qilw@cpu.edu.cn, Tel.:/Fax: +86 25 86185559.
Published 2025-3-1
Citation:
Liu Q, Zhang FG, Zhang WS, Pan A, Yang YL, Liu JF, Li P, Liu BL, Qi LW. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction: Erratum. Theranostics 2025; 15(9):3713. doi:10.7150/thno.104739. https://www.thno.org/v15p3713.htm
The authors regret to find an error in the published version of Figure 4A, wherein the AKT band in HFD-fed mice was misused due to labeling errors during the figure compilation process. The authors had checked the original data and replaced the AKT band in the HFD-fed group in Fig. 4A with the correct one. The corrected version of Figure 4A is presented below. The corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience that the errors may have caused.
Figure 4
Correct image of Figure 4A.
Author contact
Corresponding author: Dr. Lian-Wen Qi, Clinical Metabolomics Center, China Pharmaceutical University, No. 639 Longmian Road, Nanjing 211198, China, Email: Qilw@cpu.edu.cn, Tel.:/Fax: +86 25 86185559.
Liu Q, Zhang FG, Zhang WS, Pan A, Yang YL, Liu JF, Li P, Liu BL, Qi LW. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction: Erratum. Theranostics 2025; 15(9):3713. doi:10.7150/thno.104739. https://www.thno.org/v15p3713.htm
CSE
Liu Q, Zhang FG, Zhang WS, Pan A, Yang YL, Liu JF, Li P, Liu BL, Qi LW. 2025. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction: Erratum. Theranostics. 15(9):3713.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.